|
|
|
Corporate Profile: DiaDexus
| Summary: |
DiaDexus is
a company formed as a joint venture between SmithKline
Beecham Corp. and Incyte Pharmaceuticals, Inc., dedicated
to the discovery and commercialization of novel molecular
diagnostics. |
| Address (HQ):
|
|
349 Oyster Point Blvd
South San Francisco, CA 94080-1913
|
| Phone #'s (HQ): |
Main |
(650) 246-6400 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Fax #'s (HQ): |
Main |
(650) 246-6499 |
| Human Resources |
(650) 246-6499 |
| Investor Relations |
not known |
| email: |
Main |
not known |
| Human Resources |
hr@diadexus.com |
| Investor Relations |
not known |
| Financial
information: |
| not
known |
| Number
of employees: |
| not
known |
| Issued United States patents: |
Issued U.S. patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
